search
Back to results

Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach

Primary Purpose

Cervical Radiculopathy

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Transforaminal ESI with dexamethasone
Transforaminal catheter-targeted ESI with triamcinolone
Dexamethasone Sodium Phosphate 10 MG/ML
Lidocaine
Triamcinolone Acetonide 40mg/mL
Sponsored by
University of Utah
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cervical Radiculopathy focused on measuring cervical epidural steroid injection, transforaminal approach, epidural catheter targeted, interlaminar approach, cervical radicular pain

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18-80.
  • Clinical diagnosis of unilateral C4-C8 radicular pain.
  • Magnetic resonance imaging pathology consistent with clinical symptoms/signs.
  • Numerical Rating Scale (NRS) pain score of 4 or higher.
  • Pain duration of more than 6 weeks despite trial of conservative therapy (medications, physical therapy, or chiropractic care).

Exclusion Criteria:

  • Refusal to participate, provide consent, or provide follow-up information for the 6-month duration of the study.
  • Contraindications to Cervical Epidural Steroid Iinjection (CESI) (active infection, bleeding disorders, current anticoagulant or antiplatelet medication use, allergy to medications used for Cervical epidural steroid injection (CESI), and pregnancy).
  • Cervical spinal cord lesions; cerebrovascular, demyelinating, or other neuro-muscular muscular disease.
  • Current glucocorticoid use or Epidural Steroid Injection (ESI) within past 6 months.
  • Prior cervical spine surgery.
  • Patient request for or requirement of conscious sedation for the injection procedure.

Sites / Locations

  • University of Utah Orthopaedic Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Transforaminal ESI with dexamethasone

Transforaminal catheter-targeted ESI with triamcinolone

Arm Description

Group 1: Transforaminal cervical ESI with dexamethasone sodium phosphate

Group 2: Catheter-targeted cervical ESI with triamcinolone acetonide

Outcomes

Primary Outcome Measures

The Percentage of Participants With Reduction of 50% or More of Neck and Arm Pain NRS Score
The Percentage of Participants with Reduction of 50% or More of Neck and Arm Pain NRS score

Secondary Outcome Measures

Neck Disability Index-5
Percentage of patients with >30% improvement in Neck Disability Index-5 score.
Percentage of Participants Reporting >6.8 Reduction on the Medication Quantification Scale III
The Medication Quantification Scale (MQS) is an instrument used for clinical and research applications for quantifying medication regimen use in chronic pain populations. A 6.8 point reduction is considered equivalent to 10 morphine eqivalents.
The Percentage of Participants Reporting Patient Global Impression of Change Score of 6-7 (Indicating "Much Improved" and "Very Much Improved")
Patient Global Impression of Change is a scale which measures participant reported satisfaction after an intervention. The outcome was measured as the percent of patients reporting a PGIC score of 6-7 (indicating "much improved" and "very much improved")

Full Information

First Posted
December 4, 2017
Last Updated
November 22, 2022
Sponsor
University of Utah
Collaborators
Epimed
search

1. Study Identification

Unique Protocol Identification Number
NCT03382821
Brief Title
Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach
Official Title
A Prospective Randomized Comparative Trial of Targeted Injection Via a Transforaminal Approach With Dexamethasone Versus an Epidural Catheter Via an Interlaminar Approach With Particulate Steroid for the Treatment of Cervical Radicular Pain
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
September 15, 2017 (Actual)
Primary Completion Date
April 15, 2020 (Actual)
Study Completion Date
August 19, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Utah
Collaborators
Epimed

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Do cervical epidural steroid injections done by transforaminal catheter targeted approach improve pain and function in patients with cervical radicular pain?
Detailed Description
Two distinct techniques used to administer epidural steroids specifically to the nerve root affected in a radicular pain syndrome, which include transforaminal access at the level of pathology and interlaminar interlaminar access at the C7-T1 level with subsequent advancement of an epidural cathether to the level of pathology. Use of an epidural catheter is necessary in order to achieve a targeted injection via an interlaminar approach in order to prevent dural puncture or direct spinal cord trauma. Anatomic studies confirm the distance between the ligamentum flavum and dura is on average, 4 mm at the C7-T1 or C6-C7 levels, but 1mm or smaller at C5-C6 and more rostral levels. Therefore, there is likely greater risk of dural puncture and spinal cord injury when "targeting" steroid delivery using only the interlaminar technique directly at the level where pathology is located (C4-C5, or C5-C6, for example). Thus, the interlaminar placement of a needle rostral to the C6-C7 level has been strongly discouraged. Both the transforaminal injection approach and the targeted catheter approach demonstrate effectiveness. Studies have demonstrated the effectiveness of transforaminal epidural steroid injection for the treatment of cervical radicular pain. Our own recent work demonstrates the clinical effectiveness of the catheter-based targeted approach. However, these two approaches have never been directly compared. Thus, we aim to compare the differences in pain reduction, medication utilization, functional outcomes, patient satisfaction, and surgical rate reduction between these two approaches to the treatment of cervical radicular pain. Cervical radicular pain is a common syndrome, often treated with epidural steroid injection (ESI). An approach that targets the therapeutic agent, corticosteroid, at the site of spinal pathology can be performed via a transforaminal approach or via a interlaminar approach at C7-T1 with subsequent epidural catheter advancement to the symptomatic level. There are no universal guidelines that recommend the use of one technique over the other. We will directly compare the clinical effectiveness of these two approaches as measured by pain reduction, medication utilization, functional outcomes, patient satisfaction, and surgical rate reduction. The results of this study will potentially influence clinical practice recommendations regarding the treatment of cervical radicular pain. If one technique proves superior, instating this technique will have implications potentially for reducing opioid use, surgery and other healthcare utilization, and general healthcare cost related to the treatment of cervical radicular pain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Radiculopathy
Keywords
cervical epidural steroid injection, transforaminal approach, epidural catheter targeted, interlaminar approach, cervical radicular pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Prospective, randomized, comparative trial
Masking
Participant
Masking Description
Each subject will be randomized into a group assignment in a 1:1 manner, #1 or #2, as outlined in the Methods section
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Transforaminal ESI with dexamethasone
Arm Type
Active Comparator
Arm Description
Group 1: Transforaminal cervical ESI with dexamethasone sodium phosphate
Arm Title
Transforaminal catheter-targeted ESI with triamcinolone
Arm Type
Active Comparator
Arm Description
Group 2: Catheter-targeted cervical ESI with triamcinolone acetonide
Intervention Type
Procedure
Intervention Name(s)
Transforaminal ESI with dexamethasone
Intervention Description
Catheter-targeted ESI via interlaminar access at the C7-T1 level with dexamethasone sodium phosphate 1.5 mL (10 mg/mL) and 1 ml 1% lidocaine (total volume 2.5 mL).
Intervention Type
Procedure
Intervention Name(s)
Transforaminal catheter-targeted ESI with triamcinolone
Intervention Description
Catheter-targeted ESI via interlaminar access at the C7-T1 level with triamcinolone acetonide 2 mL (40mg/mL) and 1 ml 1% lidocaine (total volume 3 mL).
Intervention Type
Drug
Intervention Name(s)
Dexamethasone Sodium Phosphate 10 MG/ML
Intervention Description
Transforaminal ESI with dexamethasone 1.5 mL of dexamethasone sodium phosphate in group #1
Intervention Type
Drug
Intervention Name(s)
Lidocaine
Other Intervention Name(s)
Xylocaine
Intervention Description
1 mL of 1% lidocaine as diluent for the steroid in both group #1 and group #2
Intervention Type
Drug
Intervention Name(s)
Triamcinolone Acetonide 40mg/mL
Other Intervention Name(s)
Kenalog
Intervention Description
Transforaminal catheter-targeted ESI with triamcinolone acetonide 2 mL in group #2
Primary Outcome Measure Information:
Title
The Percentage of Participants With Reduction of 50% or More of Neck and Arm Pain NRS Score
Description
The Percentage of Participants with Reduction of 50% or More of Neck and Arm Pain NRS score
Time Frame
1 month follow up
Secondary Outcome Measure Information:
Title
Neck Disability Index-5
Description
Percentage of patients with >30% improvement in Neck Disability Index-5 score.
Time Frame
1 month, 3 month, 6 month, and 1 year follow up
Title
Percentage of Participants Reporting >6.8 Reduction on the Medication Quantification Scale III
Description
The Medication Quantification Scale (MQS) is an instrument used for clinical and research applications for quantifying medication regimen use in chronic pain populations. A 6.8 point reduction is considered equivalent to 10 morphine eqivalents.
Time Frame
1 month, 3 month, 6 month, and 1 year follow up
Title
The Percentage of Participants Reporting Patient Global Impression of Change Score of 6-7 (Indicating "Much Improved" and "Very Much Improved")
Description
Patient Global Impression of Change is a scale which measures participant reported satisfaction after an intervention. The outcome was measured as the percent of patients reporting a PGIC score of 6-7 (indicating "much improved" and "very much improved")
Time Frame
1 month, 3 month, 6 month, and 1 year follow up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18-80. Clinical diagnosis of unilateral C4-C8 radicular pain. Magnetic resonance imaging pathology consistent with clinical symptoms/signs. Numerical Rating Scale (NRS) pain score of 4 or higher. Pain duration of more than 6 weeks despite trial of conservative therapy (medications, physical therapy, or chiropractic care). Exclusion Criteria: Refusal to participate, provide consent, or provide follow-up information for the 6-month duration of the study. Contraindications to Cervical Epidural Steroid Iinjection (CESI) (active infection, bleeding disorders, current anticoagulant or antiplatelet medication use, allergy to medications used for Cervical epidural steroid injection (CESI), and pregnancy). Cervical spinal cord lesions; cerebrovascular, demyelinating, or other neuro-muscular muscular disease. Current glucocorticoid use or Epidural Steroid Injection (ESI) within past 6 months. Prior cervical spine surgery. Patient request for or requirement of conscious sedation for the injection procedure.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zachary L McCormick, MD
Organizational Affiliation
University of Utah
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Utah Orthopaedic Center
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84108
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
8186959
Citation
Radhakrishnan K, Litchy WJ, O'Fallon WM, Kurland LT. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain. 1994 Apr;117 ( Pt 2):325-35. doi: 10.1093/brain/117.2.325.
Results Reference
background
PubMed Identifier
16049211
Citation
Carette S, Fehlings MG. Clinical practice. Cervical radiculopathy. N Engl J Med. 2005 Jul 28;353(4):392-9. doi: 10.1056/NEJMcp043887. No abstract available.
Results Reference
background
PubMed Identifier
10549703
Citation
Heckmann JG, Lang CJ, Zobelein I, Laumer R, Druschky A, Neundorfer B. Herniated cervical intervertebral discs with radiculopathy: an outcome study of conservatively or surgically treated patients. J Spinal Disord. 1999 Oct;12(5):396-401.
Results Reference
background
PubMed Identifier
23424170
Citation
Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol. 2013 Jul;74(1):145-8. doi: 10.1002/ana.23869. Epub 2013 Jun 17.
Results Reference
background
PubMed Identifier
21187551
Citation
Mizutamari M, Sei A, Tokiyoshi A, Fujimoto T, Taniwaki T, Togami W, Mizuta H. Corresponding scapular pain with the nerve root involved in cervical radiculopathy. J Orthop Surg (Hong Kong). 2010 Dec;18(3):356-60. doi: 10.1177/230949901001800320.
Results Reference
background
PubMed Identifier
17664368
Citation
Rhee JM, Yoon T, Riew KD. Cervical radiculopathy. J Am Acad Orthop Surg. 2007 Aug;15(8):486-94. doi: 10.5435/00124635-200708000-00005.
Results Reference
background
PubMed Identifier
9247921
Citation
Malanga GA. The diagnosis and treatment of cervical radiculopathy. Med Sci Sports Exerc. 1997 Jul;29(7 Suppl):S236-45. doi: 10.1097/00005768-199707001-00006.
Results Reference
background
PubMed Identifier
1719788
Citation
Renfrew DL, Moore TE, Kathol MH, el-Khoury GY, Lemke JH, Walker CW. Correct placement of epidural steroid injections: fluoroscopic guidance and contrast administration. AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):1003-7.
Results Reference
background
PubMed Identifier
4061788
Citation
Mehta M, Salmon N. Extradural block. Confirmation of the injection site by X-ray monitoring. Anaesthesia. 1985 Oct;40(10):1009-12. doi: 10.1111/j.1365-2044.1985.tb10558.x.
Results Reference
background
PubMed Identifier
11880836
Citation
Stojanovic MP, Vu TN, Caneris O, Slezak J, Cohen SP, Sang CN. The role of fluoroscopy in cervical epidural steroid injections: an analysis of contrast dispersal patterns. Spine (Phila Pa 1976). 2002 Mar 1;27(5):509-14. doi: 10.1097/00007632-200203010-00011.
Results Reference
background
PubMed Identifier
19807874
Citation
Van Zundert J, Huntoon M, Patijn J, Lataster A, Mekhail N, van Kleef M; Pain Practice. 4. Cervical radicular pain. Pain Pract. 2010 Jan-Feb;10(1):1-17. doi: 10.1111/j.1533-2500.2009.00319.x. Epub 2009 Oct 5.
Results Reference
background
PubMed Identifier
2167604
Citation
Johansson A, Hao J, Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand. 1990 Jul;34(5):335-8. doi: 10.1111/j.1399-6576.1990.tb03097.x.
Results Reference
background
PubMed Identifier
19165300
Citation
Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician. 2009 Jan-Feb;12(1):137-57.
Results Reference
background
PubMed Identifier
8213020
Citation
Stav A, Ovadia L, Sternberg A, Kaadan M, Weksler N. Cervical epidural steroid injection for cervicobrachialgia. Acta Anaesthesiol Scand. 1993 Aug;37(6):562-6. doi: 10.1111/j.1399-6576.1993.tb03765.x.
Results Reference
background
PubMed Identifier
7816491
Citation
Castagnera L, Maurette P, Pointillart V, Vital JM, Erny P, Senegas J. Long-term results of cervical epidural steroid injection with and without morphine in chronic cervical radicular pain. Pain. 1994 Aug;58(2):239-243. doi: 10.1016/0304-3959(94)90204-6.
Results Reference
background
PubMed Identifier
8875719
Citation
Saal JS, Saal JA, Yurth EF. Nonoperative management of herniated cervical intervertebral disc with radiculopathy. Spine (Phila Pa 1976). 1996 Aug 15;21(16):1877-83. doi: 10.1097/00007632-199608150-00008.
Results Reference
background
PubMed Identifier
11097449
Citation
Riew KD, Yin Y, Gilula L, Bridwell KH, Lenke LG, Lauryssen C, Goette K. The effect of nerve-root injections on the need for operative treatment of lumbar radicular pain. A prospective, randomized, controlled, double-blind study. J Bone Joint Surg Am. 2000 Nov;82(11):1589-93. doi: 10.2106/00004623-200011000-00012.
Results Reference
background
PubMed Identifier
15069129
Citation
Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am. 2004 Apr;86(4):670-9.
Results Reference
background
PubMed Identifier
16055268
Citation
Huntoon MA. Anatomy of the cervical intervertebral foramina: vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain. 2005 Sep;117(1-2):104-11. doi: 10.1016/j.pain.2005.05.030.
Results Reference
background
PubMed Identifier
17762818
Citation
Abbasi A, Malhotra G, Malanga G, Elovic EP, Kahn S. Complications of interlaminar cervical epidural steroid injections: a review of the literature. Spine (Phila Pa 1976). 2007 Sep 1;32(19):2144-51. doi: 10.1097/BRS.0b013e318145a360.
Results Reference
background
PubMed Identifier
25668411
Citation
Rathmell JP, Benzon HT, Dreyfuss P, Huntoon M, Wallace M, Baker R, Riew KD, Rosenquist RW, Aprill C, Rost NS, Buvanendran A, Kreiner DS, Bogduk N, Fourney DR, Fraifeld E, Horn S, Stone J, Vorenkamp K, Lawler G, Summers J, Kloth D, O'Brien D Jr, Tutton S. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology. 2015 May;122(5):974-84. doi: 10.1097/ALN.0000000000000614.
Results Reference
background
PubMed Identifier
27922950
Citation
McCormick ZL, Nelson A, Bhave M, Zhukalin M, Kendall M, McCarthy RJ, Khan D, Nagpal G, Walega DR. A Prospective Randomized Comparative Trial of Targeted Steroid Injection Via Epidural Catheter Versus Standard C7-T1 Interlaminar Approach for the Treatment of Unilateral Cervical Radicular Pain. Reg Anesth Pain Med. 2017 Jan-Feb;42(1):82-89. doi: 10.1097/AAP.0000000000000521.
Results Reference
background
PubMed Identifier
17456677
Citation
Ackerman WE 3rd, Ahmad M. The efficacy of lumbar epidural steroid injections in patients with lumbar disc herniations. Anesth Analg. 2007 May;104(5):1217-22, tables of contents. doi: 10.1213/01.ane.0000260307.16555.7f.
Results Reference
background
PubMed Identifier
22086091
Citation
Gharibo CG, Varlotta GP, Rhame EE, Liu EC, Bendo JA, Perloff MD. Interlaminar versus transforaminal epidural steroids for the treatment of subacute lumbar radicular pain: a randomized, blinded, prospective outcome study. Pain Physician. 2011 Nov-Dec;14(6):499-511.
Results Reference
background
PubMed Identifier
17066121
Citation
Schaufele MK, Hatch L, Jones W. Interlaminar versus transforaminal epidural injections for the treatment of symptomatic lumbar intervertebral disc herniations. Pain Physician. 2006 Oct;9(4):361-6.
Results Reference
background
PubMed Identifier
25212440
Citation
Deyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Focus article: report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Eur Spine J. 2014 Oct;23(10):2028-45. doi: 10.1007/s00586-014-3540-3.
Results Reference
background
PubMed Identifier
19836888
Citation
Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain. 2009 Dec;146(3):238-244. doi: 10.1016/j.pain.2009.08.019.
Results Reference
background
PubMed Identifier
18402665
Citation
Kovacs FM, Abraira V, Royuela A, Corcoll J, Alegre L, Tomas M, Mir MA, Cano A, Muriel A, Zamora J, Del Real MT, Gestoso M, Mufraggi N; Spanish Back Pain Research Network. Minimum detectable and minimal clinically important changes for pain in patients with nonspecific neck pain. BMC Musculoskelet Disord. 2008 Apr 10;9:43. doi: 10.1186/1471-2474-9-43.
Results Reference
background
PubMed Identifier
18211588
Citation
Gallizzi M, Gagnon C, Harden RN, Stanos S, Khan A. Medication Quantification Scale Version III: internal validation of detriment weights using a chronic pain population. Pain Pract. 2008 Jan-Feb;8(1):1-4. doi: 10.1111/j.1533-2500.2007.00163.x.
Results Reference
background

Learn more about this trial

Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach

We'll reach out to this number within 24 hrs